Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMontreal Heart Institute
About this trial
The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.
Eligibility criteria
Qualifiers
18 years of age or older, capable to provide informed consent;
Referred for a FDG-PET/CT study
Classified as having Possible IE prior to FDG-PET/CT imaging;
Patients must be able to tolerate the physical/logistical requirements of a PET/CT scan.
Disqualifiers
Subjects with prosthetic cardiac valve and/or CIED;
Pregnant or breastfeeding female;
Body mass index > 45 kg/m2.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
97 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov